MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors-Reference-Cited by-同舟云学术

MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors

Published:2022-11 Issue:8 Volume:41 Page:111704
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Urbanski Laura,Brugiolo Mattia,Park SungHee^ORCID,Angarola Brittany L.,Leclair Nathan K.^ORCID,Yurieva Marina,Palmer Phil^ORCID,Sahu Sangram Keshari,Anczuków Olga^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference127 articles.

1. Roles and mechanisms of alternative splicing in cancer - implications for care;Bonnal;Nat. Rev. Clin. Oncol.,2020

2. Alternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics;Urbanski;Wiley Interdiscip. Rev. RNA,2018

3. The SR protein family of splicing factors: master regulators of gene expression;Long;Biochem. J.,2009

4. RNA splicing factors as oncoproteins and tumour suppressors;Dvinge;Nat. Rev. Cancer,2016

5. The spliceosome as a target of novel antitumour drugs;Bonnal;Nat. Rev. Drug Discov.,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulforaphane reverses the enhanced NSCLC metastasis by regulating the miR-7-5p/c-Myc/LDHA axis in the acidic tumor microenvironment;Phytomedicine;2024-10

2. Autoregulated splicing of TRA2 β programs T cell fate in response to antigen-receptor stimulation;Science;2024-09-13

3. The Exon Junction Complex component EIF4A3 plays a splicing-linked oncogenic role in pancreatic ductal adenocarcinoma;Cancer Gene Therapy;2024-09-04

4. Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer;Oncogene;2024-08-20

5. Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma;Advanced Science;2024-07-17